Our research work has shown that gut bacteria are required to drive inflammation in a mouse model of colitis, and that these same bacteria are associated with the risk of relapse in patients with CD. Despite the known limitations of incomplete human bacterial transfer into germ-free mice, our model captured key features of the disease-associated microbiome signatures.